FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to laboratory diagnostics. Method for early diagnosis of carbohydrate metabolism disorders involves determining the level of specific IgE to insulin (kE/l) by solid-phase non-competitive indirect enzyme immunoassay (EIA), insulin level (mcU/ml) using a two-stage "sandwich" version of solid-phase EIA in blood serum, calculating the IgE-insulin index (IgE/I) based on calculating the ratio of the IgE level to insulin to the insulin level, wherein the index is more than 5.0 - the normal level of carbohydrate metabolism; index 4.0–4.9 - boundary situation; index 3.0–3.9 - progressive index decrease - carbohydrate metabolism disturbance, predisposition to diabetes mellitus; index 2.1–2.9 - manifested carbohydrate metabolism disorder, concealed diabetes; index less than 2.0 - impaired glucose tolerance and diabetes mellitus.
EFFECT: invention can be used for detection of carbohydrate metabolism disorders at early stages and detection of concealed diabetes against background of normal glucose and glycosylated hemoglobin.
1 cl, 2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF OPTIMIZATION OF OXYGEN-DEPENDENT PROCESSES WITH PROLONGED ADMINISTRATION OF SIMVASTATIN TO ANIMALS WITH USING LIPOIC ACID | 2020 |
|
RU2741689C1 |
METHOD OF SELECTING MEN AT PRE-DIABETES RISK GROUP AND TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2695322C2 |
DIAGNOSTIC TECHNIQUE FOR EARLY DISORDERS OF CARBOHYDRATE METABOLISM IN PATIENTS WITH CHRONIC PANCREATITIS | 2023 |
|
RU2824803C1 |
METHOD FOR PREDICTION OF SEVERE CLINICAL COURSE OF DIABETIC POLYNEUROPATHY AND DEVELOPMENT OF DIABETIC FOOT SYNDROME | 2018 |
|
RU2687978C1 |
METHOD FOR SELECTING DRUGS IN TREATING HYPERTENSION DISEASE IN PATIENTS SUFFERING FROM ADIPOSITY | 2000 |
|
RU2161958C1 |
METHOD FOR SCREENING DIAGNOSIS OF INSULIN RESISTANCE | 2012 |
|
RU2493566C1 |
METHOD FOR COMBINED USE OF INTRANASALLY ADMINISTERED INSULIN AND ORALLY ADMINISTERED METFORMIN FOR RECOVERY OF METABOLIC AND HORMONAL PARAMETERS IN TYPE 2 DIABETES MELLITUS AND METABOLIC SYNDROME | 2023 |
|
RU2824275C1 |
METHOD OF LATENT INSULIN RESISTANCE DETECTION | 2008 |
|
RU2367339C1 |
METHOD OF REDUCING LEVEL OF GLYCEMIA AND INSULIN-RESISTANCE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2010 |
|
RU2428181C1 |
METHOD FOR INSULIN RESISTANCE CORRECTION IN METABOLIC SYNDROME | 2009 |
|
RU2402326C1 |
Authors
Dates
2019-07-19—Published
2018-06-08—Filed